EverythingALS and Vision 2030 Invest in Allen Institute Initiative to Accelerate ALS Research

SAN FRANCISCO--(BUSINESS WIRE)--Lou Gehrig Day — EverythingALS, a nonprofit dedicated to accelerating research, technology, and patient access for amyotrophic lateral sclerosis (ALS), and Vision 2030 are partnering with the Allen Institute to accelerate research into ALS disease progression and to identify new targets that could form the basis for novel medicines to treat the disease. This ALS-focused research will be supported by EverythingALS and Vision 2030’s $1M initial investment in the ne